Universe Pharmaceuticals (UPC) Competitors $0.64 +0.00 (+0.31%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends UPC vs. NEXI, BDRX, PRFX, TFFP, BLPH, SEEL, CLVR, VAXX, EVLO, and SCPSShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include NexImmune (NEXI), Biodexa Pharmaceuticals (BDRX), PainReform (PRFX), TFF Pharmaceuticals (TFFP), Bellerophon Therapeutics (BLPH), Seelos Therapeutics (SEEL), Clever Leaves (CLVR), Vaxxinity (VAXX), Evelo Biosciences (EVLO), and Scopus BioPharma (SCPS). These companies are all part of the "pharmaceutical preparations" industry. Universe Pharmaceuticals vs. NexImmune Biodexa Pharmaceuticals PainReform TFF Pharmaceuticals Bellerophon Therapeutics Seelos Therapeutics Clever Leaves Vaxxinity Evelo Biosciences Scopus BioPharma NexImmune (NASDAQ:NEXI) and Universe Pharmaceuticals (NYSE:UPC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, community ranking, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability. Does the MarketBeat Community believe in NEXI or UPC? NexImmune received 22 more outperform votes than Universe Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformNexImmuneOutperform Votes2261.11% Underperform Votes1438.89% Universe PharmaceuticalsN/AN/A Does the media favor NEXI or UPC? In the previous week, NexImmune's average media sentiment score of 0.00 equaled Universe Pharmaceuticals'average media sentiment score. Company Overall Sentiment NexImmune Neutral Universe Pharmaceuticals Neutral Do insiders & institutionals hold more shares of NEXI or UPC? 9.9% of NexImmune shares are owned by institutional investors. Comparatively, 0.2% of Universe Pharmaceuticals shares are owned by institutional investors. 14.9% of NexImmune shares are owned by insiders. Comparatively, 57.4% of Universe Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has stronger earnings and valuation, NEXI or UPC? Universe Pharmaceuticals has higher revenue and earnings than NexImmune. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexImmuneN/AN/A-$32.34M-$18.54-0.01Universe Pharmaceuticals$26.73M0.04-$6.16MN/AN/A Which has more volatility and risk, NEXI or UPC? NexImmune has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500. Comparatively, Universe Pharmaceuticals has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500. Is NEXI or UPC more profitable? Universe Pharmaceuticals' return on equity of 0.00% beat NexImmune's return on equity.Company Net Margins Return on Equity Return on Assets NexImmuneN/A -534.32% -213.72% Universe Pharmaceuticals N/A N/A N/A SummaryUniverse Pharmaceuticals beats NexImmune on 5 of the 8 factors compared between the two stocks. Ad Porter & CompanyHow to piss off your liberal friends… and profit from itElon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$1.09M$6.57B$5.14B$19.18BDividend YieldN/A2.99%5.09%3.63%P/E RatioN/A10.5990.0541.26Price / Sales0.04196.061,116.2517.51Price / CashN/A57.1643.1021.28Price / Book0.005.094.785.32Net Income-$6.16M$151.83M$120.31M$989.88M7 Day Performance-17.43%-2.14%-1.92%-3.54%1 Month Performance-66.99%-4.56%13.65%-4.73%1 Year Performance-96.76%8.87%28.34%11.57% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse PharmaceuticalsN/A$0.64+0.3%N/A-96.4%$1.09M$26.73M0.00225NEXINexImmuneN/A$0.38+64.1%N/A-89.7%$526,000.00N/A-0.016BDRXBiodexa Pharmaceuticals1.5878 of 5 stars$4.27+1.7%$200.00+4,583.8%N/A$508,000.00$83,000.000.0021PRFXPainReform1.7826 of 5 stars$2.93-5.8%$8.00+173.0%-47.6%$410,000.00N/A-0.024News CoverageGap UpTFFPTFF Pharmaceuticals2.1493 of 5 stars$0.07flat$44.00+67,592.3%N/A$289,000.00$730,000.00-0.0119Positive NewsBLPHBellerophon Therapeutics0.8483 of 5 stars$0.02+55.7%N/A-62.5%$232,000.00$5.64M-0.0220Dividend AnnouncementAnalyst ForecastNews CoverageGap UpSEELSeelos TherapeuticsN/A$0.30-14.5%N/A-99.8%$110,000.00$2.20M0.0020CLVRClever LeavesN/A$0.03flatN/A-100.0%$48,000.00$17.42M0.00560VAXXVaxxinityN/A$0.00+100.0%N/A-100.0%$25,000.00$70,000.000.0090EVLOEvelo BiosciencesN/A$0.00+25.0%N/A-99.1%$9,000.00N/A0.00120SCPSScopus BioPharmaN/A$0.00-33.3%N/A-99.3%$8,000.00N/A0.009Gap Down Related Companies and Tools Related Companies NEXI Alternatives BDRX Alternatives PRFX Alternatives TFFP Alternatives BLPH Alternatives SEEL Alternatives CLVR Alternatives VAXX Alternatives EVLO Alternatives SCPS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:UPC) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThis is the worst sign for the U.S. stock market in 50 yearsThe Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts no...Stansberry Research | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UPC Stock Alerts